Cardiac rhythm management, a part of electrophysiology, is a field of cardiovascular disease therapy that provides treatment and diagnosis for heart disorders. Cardiac rhythm management devices (including implantable defibrillators and bi ventricular pacemakers) are used to manage heart rhythm problems such as bradycardia and tachycardia.
Rise in cholesterol levels, hypertension, and excessive smoking lead to high risks of cardiac disorders, resulting in the growing need for cardiovascular therapeutic instruments such as CRT devices. Governments and organizations in many countries implement various initiatives to educate and help people to make medical decisions, increase public awareness, and improve the quality of life. Pacemakers, ICDs, and CRT devices are used to treat arrhythmias and are considered as a standard treatment option in many countries.
Technavio's analysts forecast the global cardiac rhythm management devices market to grow at a CAGR of 1.08% over the period 2014-2019.
The report includes the present scenario and the growth prospects of the global cardiac rhythm management devices market for the period 2015-2019. Based on product types, the market can be segmented into: pacemaker, ICD, and CRT (including CRT-D and CRT-P).
Technavio's report, Global Cardiac Rhythm Management Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global cardiac rhythm management devices market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Browse more Cardiovascular Device Market Research Reports